BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund strategically managed to achieve high total returns through a diversified portfolio concentrated in the health sciences sector, including pharmaceuticals, biotechnology, and medical devices. Leveraging the extensive expertise of BlackRock, a premier global investment manager, BMEZ targets significant growth opportunities driven by demographic trends and rising healthcare expenditures. Its disciplined investment strategy positions the fund as an attractive option for institutional investors aiming to enhance their portfolios while capitalizing on the evolving landscape of health sciences innovation.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.82 |
| Price-to-Sales (TTM) | 8.66 |
| EV/Revenue | 8.66 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $62.50M |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 21.56% |
Volatility is currently contracting